- Report
- December 2022
- 117 Pages
Global
From €4163EUR$4,500USD£3,501GBP
- Report
- September 2024
- 150 Pages
Mexico
From €3329EUR$3,599USD£2,800GBP
- Report
- April 2024
- 140 Pages
Global
From €4578EUR$4,949USD£3,850GBP
From €2580EUR$2,789USD£2,170GBP
- Report
- December 2023
- 221 Pages
Global
From €3329EUR$3,599USD£2,800GBP
- Report
- October 2023
- 140 Pages
Global
From €3329EUR$3,599USD£2,800GBP
- Report
- September 2023
- 160 Pages
Global
From €3329EUR$3,599USD£2,800GBP
- Report
- September 2023
- 160 Pages
Global
From €3329EUR$3,599USD£2,800GBP
- Report
- September 2023
- 140 Pages
Global
From €3329EUR$3,599USD£2,800GBP
- Report
- July 2023
- 140 Pages
Global
From €4578EUR$4,949USD£3,850GBP
- Report
- December 2023
- 146 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- December 2023
- 150 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- October 2023
- 90 Pages
United Kingdom
From €3099EUR$3,350USD£2,606GBP
- Report
- October 2021
- 115 Pages
Global
From €4117EUR$4,450USD£3,462GBP
- Report
- April 2020
- 80 Pages
United States
From €2498EUR$2,700USD£2,101GBP
- Report
- February 2024
- 50 Pages
United States
From €324EUR$350USD£272GBP
- Report
- October 2023
- 77 Pages
United States
From €3238EUR$3,500USD£2,723GBP
- Report
- May 2024
- 140 Pages
Global
From €4578EUR$4,949USD£3,850GBP
- Report
- April 2023
- 119 Pages
Global
From €4163EUR$4,500USD£3,501GBP
- Report
- August 2022
- 118 Pages
Global
From €4163EUR$4,500USD£3,501GBP

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more